Shakil Aslam - 12 Feb 2026 Form 4 Insider Report for TALPHERA, INC. (TLPH)

Reporting relationship: Chief Medical Officer
Issuer ticker: TLPH
Reported as of: 12 Feb 2026
Net transaction value: +$28,430
SEC form: 4
Accepted by SEC: 20 Feb 2026, 20:27:03 UTC
Prior SEC filing: 21 May 2025
Next SEC filing: 03 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Martha Adler, Attorney-in-Fact

Key filing fact

Shakil Aslam filed Form 4 for TALPHERA, INC. (TLPH) on 20 Feb 2026.

Key facts

This page summarizes Shakil Aslam's Form 4 filing for TALPHERA, INC. (TLPH).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 20 Feb 2026, 20:27.

Change

Previous filing in this sequence was filed on 21 May 2025.
Current net transaction value: +$28,430.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002040805 Primary reporting owner

Aslam Shakil

Relationship: Chief Medical Officer
Address: C/O TALPHERA, INC., 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO
Signature: /s/ Martha Adler, Attorney-in-Fact
Signature date: 20 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLPH transaction

Common Stock

Purchase

Transaction value: $28,430
Shares: +35,000
Change %: +73%
Price: $0.8123
Shares after: 83,178
Date: 12 Feb 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TLPH transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +205,000
Change %
Price: $0.000000
Shares after: 205,000
Date: 12 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 205,000
Exercise price: $0.8123
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units shall vest in three equal consecutive annual installments on February 12, 2027, February 12, 2028 and February 12, 2029.

Footnote F2

On February 12, 2026, the reporting person was granted an option to purchase 205,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods.